Home » Topics » BioWorld

BioWorld
RSS

BIOTECH CENTER FUNDS COLLABORATION

April 30, 1991

GENELABS FILES FOR 3 MILLION-SHARE IPO

April 30, 1991

XOMA TO ISSUE SHARES TO REDEEM DEBENTURES

April 30, 1991

JOURNAL SCAN ANTI-TAC-H INHIBITS TISSUE REJECTION

April 30, 1991

STOCK CONTEST MAKING MONEY THE EASY WAY

April 30, 1991

EARNINGS REPORTS

April 29, 1991

NEWS BRIEFS

April 29, 1991

APPOINTMENTS AND ADVANCEMENTS

April 29, 1991

GLIATECH LICENSES NERVE THERAPY TECHNOLOGIES

April 29, 1991

PROPOSED ORPHAN ACT CHANGES ATTACKED

April 29, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...